Jump to content

User:FrancoThomas87/sandbox: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
4 new sections added- introduction, history, overview and funding with reference
added a new section "cyto-mine technology" and added more references to the overall content along with the internal links.
Line 17: Line 17:


== History ==
== History ==
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of [[Cambridge University]], namely, Professor [[Chris Abell]] and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.<ref>{{Cite news|url=http://realbusiness.co.uk/tech-and-innovation/2015/03/04/sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive/|title=Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business|date=2015-03-04|work=Real Business|access-date=2017-09-13|language=en-US}}</ref>
Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of [[Cambridge University]], namely, Professor [[Chris Abell]]<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/cambridge-torchbearers/farm-fame-cambridge%E2%80%99s-%E2%80%98cereal%E2%80%99-life-science-entrepreneur|title=From farm to fame, Cambridge’s ‘cereal’ life science entrepreneur {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref> and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.<ref>{{Cite news|url=http://realbusiness.co.uk/tech-and-innovation/2015/03/04/sphere-fluidics-single-cell-analysis-has-never-looked-so-disruptive/|title=Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business|date=2015-03-04|work=Real Business|access-date=2017-09-13|language=en-US}}</ref>


In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-award-for-academic-spin-outs/|title=Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite web|url=https://www.labmate-online.com/news/news-and-views/5/university_of_cambridge/sphere_fluidics_wins_award_for_academic_spin-outs/25787|title=Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online|website=www.labmate-online.com|language=en|access-date=2017-09-13}}</ref>
In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-award-for-academic-spin-outs/|title=Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite web|url=https://www.labmate-online.com/news/news-and-views/5/university_of_cambridge/sphere_fluidics_wins_award_for_academic_spin-outs/25787|title=Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online|website=www.labmate-online.com|language=en|access-date=2017-09-13}}</ref>
Line 24: Line 24:
In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.<ref name=":0" />
In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.<ref name=":0" />


In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants<ref>{{Cite web|url=http://metispartners.com/ip-league-table-2-2/intellectual-property-league-table-2015-results/|title=2015 Results - Autumn Update {{!}} Metis Partners|website=metispartners.com|language=en-US|access-date=2017-09-13}}</ref>. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks.
In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants<ref>{{Cite web|url=http://metispartners.com/ip-league-table-2-2/intellectual-property-league-table-2015-results/|title=2015 Results - Autumn Update {{!}} Metis Partners|website=metispartners.com|language=en-US|access-date=2017-09-13}}</ref>. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks.<ref>{{Cite web|url=https://www.ipo.gov.uk/p-journal/p-pj/p-pj?lastResult=430&perPage=10&startYear=2015&startMonth=October&startDay=28th+-+6597&endYear=2017&endMonth=May&endDay=17th+-+6678&filter=&sort=Publication+Date&status=undefined|title=Intellectual Property Office - Patents Journal : UK applications filed|last=information@ipo.gov.uk|first=Intellectual Property Office, Concept House, Cardiff Road, Newport, NP10 8QQ.|website=www.ipo.gov.uk|language=English|access-date=2017-09-13}}</ref>


In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.<ref>{{Cite news|url=https://www.scientifictechnologynews.com/sphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-specialist-microfluidic-products/|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News|date=2017-01-24|work=Scientific Technology News|access-date=2017-09-13|language=en-US}}</ref>
In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.<ref>{{Cite news|url=https://biopharmadealmakers.nature.com/users/7626-sphere-fluidics/posts/14600-ssphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-to-specialist-microfluidic-product|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products|last=Dealmakers|first=BioPharma|date=2017-01-24|work=BioPharma Dealmakers|access-date=2017-09-13|language=en-GB}}</ref><ref>{{Cite news|url=https://www.scientifictechnologynews.com/sphere-fluidics-launches-e-commerce-site-allowing-researchers-rapid-access-specialist-microfluidic-products/|title=Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News|date=2017-01-24|work=Scientific Technology News|access-date=2017-09-13|language=en-US}}</ref>


In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/financial/angels-side-cambridge-trio|title=Angels on the side of Cambridge trio {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite news|url=https://www.crowdfundinsider.com/2017/07/119004-uk-angel-investment-awards-powervault-wins-best-angel-crowdfunding-investment-digital-fineprint-wins-best-fintech-investment/|title=UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment {{!}} Crowdfund Insider|date=2017-07-08|work=Crowdfund Insider|access-date=2017-09-13|language=en-US}}</ref>
In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.<ref>{{Cite web|url=http://www.businessweekly.co.uk/news/financial/angels-side-cambridge-trio|title=Angels on the side of Cambridge trio {{!}} Business Weekly {{!}} Technology News {{!}} Business news {{!}} Cambridge and the East of England|website=www.businessweekly.co.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite news|url=https://www.crowdfundinsider.com/2017/07/119004-uk-angel-investment-awards-powervault-wins-best-angel-crowdfunding-investment-digital-fineprint-wins-best-fintech-investment/|title=UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment {{!}} Crowdfund Insider|date=2017-07-08|work=Crowdfund Insider|access-date=2017-09-13|language=en-US}}</ref>
Line 33: Line 33:


== Funding ==
== Funding ==
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket, The Royal Society Enterprise Fund (acquired by Amadeus Capital Partners), Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels, Envestors, Angels5K, Cambridge Angels, Q-Ventures and a Japanese corporate investor.
Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket<ref>{{Cite web|url=http://www.globaluniversityventuring.com/article.php/3633/investment-flows-towards-sphere-fluidics|title=Investment flows towards Sphere Fluidics · Articles · Global University Venturing|website=www.globaluniversityventuring.com|access-date=2017-09-13}}</ref>, [[Amadeus Capital Partners]], Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels<ref>{{Cite news|url=http://www.bmmagazine.co.uk/get-funded/success-stories/london-business-angels-investment-helps-sphere-fluidics-close-1-6m-early-stage-funding-round/|title=London Business Angels investment helps Sphere Fluidics close £1.6m early stage funding round|date=2013-03-10|work=Business Matters|access-date=2017-09-13|language=en-GB}}</ref>, Envestors, Angels5K, [[Cambridge Angels]], Q-Ventures and a Japanese corporate investor.<ref name=":1">{{Cite web|url=https://www.gov.uk/government/news/sphere-fluidics-biotherapeutics-device-attracts-7m-investment|title=Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK|website=www.gov.uk|language=en|access-date=2017-09-13}}</ref><ref>{{Cite web|url=https://www.cambridgenetwork.co.uk/news/sphere-fluidics-closes-a-1pt6m-series-a-investment-round/|title=Sphere Fluidics successfully closes a £1.6 million Series A investment round|website=Cambridge Network|language=en|access-date=2017-09-13}}</ref>

== Cyto-Mine Technology ==
Cyto-Mine Technology is one of the [[Patent|patented]] products of Sphere Fluidics.<ref>{{Cite web|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=433708|title=Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"! {{!}} Evaluate|website=www.evaluategroup.com|access-date=2017-09-13}}</ref>

Cyto-Mine technology is the integrated device that is able to automatically perform [[Single-cell analysis|single cell analysis]], sorting, imaging and dispensing into individual wells of microtitre plates in a single compact system.<ref name=":1" /> Based on the research made by Professors Chris Abell and Wilhelm Huck, this biochip system can automatically process millions to billions of miniaturised tests in tiny picodroplets.<ref>{{Cite news|url=https://www.enterprise.cam.ac.uk/news/sphere-fluidics-wins-7-million-for-development-of-single-cell-analysis-system/|title=Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise|last=site.|first=Who made this|work=Cambridge Enterprise|access-date=2017-09-13|language=en-GB}}</ref>

According to the scientists of Sphere Fluidics, Cyto-Mine can perform millions of single-cell assays daily, offering up to a 100-fold improvement over conventional techniques, at lower capital and operational cost. <ref name=":1" />


== References ==
== References ==

Revision as of 07:56, 13 September 2017

Sphere Fluidics Limited
FoundedFebruary 24, 2010; 14 years ago (2010-02-24)
FoundersProfessor Chris Abell, Frank. F.Craig, Professor Wilhelm Huck, and Dr.Maher Khaled
TypePrivate
HeadquartersBabraham, United Kingdom
Servicesanti-microbial screening, synthetic biology, and genome editing of single cells.
Websitespherefluidics.com

Sphere Fluidics Limited

Sphere Fluidics is an England-based Life Sciences Research and Development company specializing in biopharmaceutical discovery and development, cell therapy engineering, analysis and isolation.[1] Sphere Fluidics has been named one of the UK's top 50 disruptive SMEs by Real Business in 2015.[2]

History

Sphere Fluidics Limited was originally established in 2010, by two chemistry professors of Cambridge University, namely, Professor Chris Abell[3] and Professor Wilhelm Huck along with Frank F.Craig, an entrepreneur, and Dr.Maher Khaled, a Cambridge University Enterprise.[4]

In 2013, Sphere Fluidics spun out of Cambridge university to a new research facility in Babraham Research Campus. In 2013, Sphere Fluidics won an award for academic spin-outs at the ACES awards.[5][6]

Overview

In the earlier stages, Sphere Fluidics marketed in the biopharmaceuticals industry, largely. Currently, they operate in anti-microbial screening, synthetic biology, and genome editing of single cells areas, too.[1]

In 2015, Sphere Fluidics was among the top 20 Intellectual Property League Table Entrants[7]. As of 2017, Sphere Fluidics has 36 granted patents and 16 trademarks.[8]

In January 2017, Sphere Fluidics launched an e-commerce platform which had, microfluidic products, research instrument accessories, and microfluidic biochips, on its product line.[9][10]

In July 2017, Sphere Fluidics won “Best Investment in Life Sciences” Award, in the event held by UK Business Angels Association.[11][12]

In August 2017, a new lab and facility from Sphere Fluidics was opened in Monmouth Junction, New Jersey.

Funding

Sphere Fluidics has raised £11 million as of 2017, from investors namely, 24 Haymarket[13], Amadeus Capital Partners, Greenwood Way Capital, University of Cambridge Enterprise, University of Cambridge, Parkwalk Advisors, Providence Investment Company, London Business Angels[14], Envestors, Angels5K, Cambridge Angels, Q-Ventures and a Japanese corporate investor.[15][16]

Cyto-Mine Technology

Cyto-Mine Technology is one of the patented products of Sphere Fluidics.[17]

Cyto-Mine technology is the integrated device that is able to automatically perform single cell analysis, sorting, imaging and dispensing into individual wells of microtitre plates in a single compact system.[15] Based on the research made by Professors Chris Abell and Wilhelm Huck, this biochip system can automatically process millions to billions of miniaturised tests in tiny picodroplets.[18]

According to the scientists of Sphere Fluidics, Cyto-Mine can perform millions of single-cell assays daily, offering up to a 100-fold improvement over conventional techniques, at lower capital and operational cost. [15]

References

  1. ^ a b "Sphere Fluidics Raises $7 Million for Development Of Cyto-Mine Single Cell Analysis System - SynBioBeta". synbiobeta.com. Retrieved 2017-09-13.
  2. ^ site., Who made this. "Sphere Fluidics named one of Britain's most disruptive businesses - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
  3. ^ "From farm to fame, Cambridge's 'cereal' life science entrepreneur | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
  4. ^ "Sphere Fluidics: Single cell analysis has never looked so disruptive - Real Business". Real Business. 2015-03-04. Retrieved 2017-09-13.
  5. ^ site., Who made this. "Sphere Fluidics wins award for academic spin-outs - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.
  6. ^ "Sphere Fluidics Wins Award for Academic Spin-Outs Labmate Online". www.labmate-online.com. Retrieved 2017-09-13.
  7. ^ "2015 Results - Autumn Update | Metis Partners". metispartners.com. Retrieved 2017-09-13.
  8. ^ information@ipo.gov.uk, Intellectual Property Office, Concept House, Cardiff Road, Newport, NP10 8QQ. "Intellectual Property Office - Patents Journal : UK applications filed". www.ipo.gov.uk. Retrieved 2017-09-13.{{cite web}}: CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
  9. ^ Dealmakers, BioPharma (2017-01-24). "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products". BioPharma Dealmakers. Retrieved 2017-09-13.
  10. ^ "Sphere Fluidics Launches E-commerce Site Allowing Researchers Rapid Access to Specialist Microfluidic Products - Scientific Technology News". Scientific Technology News. 2017-01-24. Retrieved 2017-09-13.
  11. ^ "Angels on the side of Cambridge trio | Business Weekly | Technology News | Business news | Cambridge and the East of England". www.businessweekly.co.uk. Retrieved 2017-09-13.
  12. ^ "UK Angel Investment Awards: Powervault Wins Best Angel Crowdfunding Investment, Digital Fineprint Wins Best Fintech Investment | Crowdfund Insider". Crowdfund Insider. 2017-07-08. Retrieved 2017-09-13. {{cite news}}: no-break space character in |title= at position 129 (help)
  13. ^ "Investment flows towards Sphere Fluidics · Articles · Global University Venturing". www.globaluniversityventuring.com. Retrieved 2017-09-13.
  14. ^ "London Business Angels investment helps Sphere Fluidics close £1.6m early stage funding round". Business Matters. 2013-03-10. Retrieved 2017-09-13.
  15. ^ a b c "Sphere Fluidics: biotherapeutics device attracts $7m investment - GOV.UK". www.gov.uk. Retrieved 2017-09-13.
  16. ^ "Sphere Fluidics successfully closes a £1.6 million Series A investment round". Cambridge Network. Retrieved 2017-09-13.
  17. ^ "Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"! | Evaluate". www.evaluategroup.com. Retrieved 2017-09-13.
  18. ^ site., Who made this. "Sphere Fluidics wins $7 million for development of single cell analysis system - Cambridge Enterprise". Cambridge Enterprise. Retrieved 2017-09-13.